Results 21 to 30 of about 954 (147)

Comparative proteomics of HepG2 cells reveals NGLY1 as an important regulator of ferroptosis resistance and iron uptake. [PDF]

open access: yesPLoS One
NGLY1 deficiency is a rare genetic disorder caused by mutations in the NGLY1 gene. This disorder presents a wide range of clinical symptoms, and its severity varies among affected individuals.
Emmerson S   +6 more
europepmc   +2 more sources

Structural and Functional Characterization of N-Glycanase-1 Pathogenic Variants [PDF]

open access: yesCells
NGLY1 deficiency is a congenital disorder of deglycosylation, caused by pathogenic variants of the NGLY1 gene. It manifests as global developmental delay, hypo- or alacrima, hypotonia, and a primarily hyperkinetic movement disorder.
Antje Banning   +6 more
doaj   +2 more sources

Erratum: [Erratum] Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease. [PDF]

open access: yesEur J Case Rep Intern Med
[This corrects the article DOI: 10.12890/2025_005886.].
Reina-Llompart N   +3 more
europepmc   +2 more sources

Reversibility of motor dysfunction in the rat model of NGLY1 deficiency [PDF]

open access: yesMolecular Brain, 2021
N-glycanase 1 (NGLY1) deficiency is a rare inherited disorder characterized by developmental delay, hypolacrima or alacrima, seizure, intellectual disability, motor deficits, and other neurological symptoms.
Makoto Asahina   +5 more
doaj   +3 more sources

Ferroptosis regulation by the NGLY1/NFE2L1 pathway [PDF]

open access: yesProceedings of the National Academy of Sciences, 2021
Ferroptosis is an oxidative form of non-apoptotic cell death whose transcriptional regulation is poorly understood. Cap’n’collar (CNC) transcription factors including Nuclear Factor Erythroid-2 Related Factor 1 (NFE2L1/NRF1) and NFE2L2 (NRF2) are ...
G. Forcina   +6 more
semanticscholar   +3 more sources

Development of a fluorescence and quencher-based FRET assay for detection of endogenous peptide:N-glycanase/NGLY1 activity. [PDF]

open access: yesJ Biol Chem
Cytosolic peptide:N-glycanase (PNGase/NGLY1 in mammals) catalyzes deglycosylation of N-glycans on glycoproteins. A genetic disorder caused by mutations in the NGLY1 gene leads to NGLY1 deficiency with symptoms including motor deficits and neurological ...
Hirayama H   +6 more
europepmc   +2 more sources

NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology

open access: yesCells, 2022
N-Glycanase 1 (NGLY1) is a cytosolic enzyme involved in removing N-linked glycans of misfolded N-glycoproteins and is considered to be a component of endoplasmic reticulum-associated degradation (ERAD).
Ashutosh Pandey   +3 more
doaj   +2 more sources

NGLY1 deficiency—A rare congenital disorder of deglycosylation

open access: yesJIMD Reports, 2020
Pathogenic variants in the NGLY1 gene are associated with a Congenital Disorder of Deglycosylation (CDDG) characterized by delays in reaching developmental milestones, complex hyperkinetic movement disorder, transient elevation of transaminases, and ...
Patrícia Lipari Pinto   +6 more
doaj   +3 more sources

Mutations in nucleotide metabolism genes bypass proteasome defects in png-1/NGLY1-deficient Caenorhabditis elegans. [PDF]

open access: yesPLoS Biol
The conserved SKN-1A/Nrf1 transcription factor regulates the expression of proteasome subunit genes and is essential for maintenance of adequate proteasome function in animal development, aging, and stress responses.
Yanagi KS   +5 more
europepmc   +2 more sources

Congenital Hypotonia: Cracking a SAGA of consanguineous kindred harboring four genetic variants

open access: yesMolecular Genetics & Genomic Medicine, 2022
Background We aimed to determine the molecular and biochemical basis of an extended highly consanguineous family with multiple children presenting severe congenital hypotonia.
Limor Kalfon   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy